no nasdaq trades, page-13

BigRedRoo -

I guess that's where are views differ & you're free to have yours but from memory you where one of those pushing the hype aswell & your entry to the company was primarily on anticipation of some kind of "explosive" action on NASDAQ listing. I for one as a long term holder from the fractions of a cent really wasn't to phased by the whole NASDAQ listing & one of the very few that said the intial result of any listing would have an immaterial effect on the companys share price the "nasbomb" was nothing more than hype being cheered from every corner on THIS forum & the expectation of a massive value building event.

So in summary "didly squat" is what i expected & the declining share price is simply a visual representation that punters where buying into the hype of some kind of magical event. People rant & rave about how the company should be $500M at this point $1B like DNDN around the corner yada yada I for one think it's really about a reasonable value for where it is at this stage of development, $200M is a significant sum especially for a company generating no revenue but significant capital injection to carry trials forward - as at this point there is no approved product $200M is on speculation that in years there will be, the more validation along the path will allow market to raise their expectations of seeing it reach the potential value in market it's not going to keep climbing on blindsided expectation yes yes people will come with the "we know it works" line but until the appoint that the FDA can stamp it as "THEY know it works" then there is really no formal validation by a market that will provide future revenue.

Anyway each to their own but if you expect watching PBMD's peformance each & everyday & expecting that to increase your wealth then i think your looking in the wrong spot. It will come from data not trades.